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functional and neurometabolic 
asymmetry in SHR and WKY rats 
following vasoactive treatments
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A lateralized distribution of neuropeptidase activities in the frontal cortex of normotensive and 
hypertensive rats has been described depending on the use of some vasoactive drugs and linked to 
certain mood disorders. Asymmetrical neuroperipheral connections involving neuropeptidases from the 
left or right hemisphere and aminopeptidases from the heart or plasma have been suggested to play 
a role in this asymmetry. We hypothesize that such asymmetries could be extended to the connection 
between the brain and physiologic parameters and metabolic factors from plasma and urine. to 
assess this hypothesis, we analyzed the possible correlation between neuropeptidases from the left 
and right frontal cortex with peripheral parameters in normotensive (Wistar Kyoto [WKY]) rats and 
hypertensive rats (spontaneously hypertensive rats [SHR]) untreated or treated with vasoactive drugs 
such as captopril, propranolol and L-nitro-arginine methyl ester. Neuropeptidase activities from the 
frontal cortex were analyzed fluorometrically using arylamide derivatives as substrates. Physiological 
parameters and metabolic factors from plasma and urine were determined using routine laboratory 
techniques. Vasoactive drug treatments differentially modified the asymmetrical neuroperipheral 
pattern by changing the predominance of the correlations between peripheral parameters and central 
neuropeptidase activities of the left and right frontal cortex. The response pattern also differed between 
SHR and WKY rats. these results support an asymmetric integrative function of the organism and 
suggest the possibility of a different neurometabolic response coupled to particular mood disorders, 
depending on the selected vasoactive drug.
The analysis of the significance of cerebral lateralization in humans, understood as a morphological, functional or 
neurochemical difference between the left and right hemispheres as well as the interaction of both, is more than 
100 years old. Lateralization remains, however, an ill-defined topic that is sometimes undervalued1,2. Brain asym-
metry is also applicable to non human species including rodents3 in which lateralized behavioral functions were 
described4. Lateralized neurochemical relationships for an asymmetrical behavior in rats5 were also described in 
early research on rat brain asymmetry. Regarding the present study, the existence of brain asymmetry in rats for 
a neuropeptidase activity (leucyl-aminopeptidase) was initially described in frontal cortex6. Various sets of data 
confirm that asymmetry extends to all organizational levels of the main internal communication systems: the 
central and peripheral nervous system as well as endocrine glands7.
An asymmetrical correlation between central neuropeptidases of the frontal cortex and peripheral peptidases 
from plasma8 and the heart9 has been reported in rats. We postulate that such a correlation may be the result of an 
integrative response of the organism and that this asymmetrical connection could be extended to a general con-
cept of neurovisceral asymmetric integration. To support our proposal and to advance the functional understand-
ing of this connection, we hypothesize that such asymmetry could be reflected in the pattern of behavior between 
the left and right brain and physiological parameters as well as metabolic factors present in plasma or urine. To 
test this hypothesis, we studied the existence of possible correlations between neuropeptidase activities in the left 
and right frontal cortex, a brain region involved in cognitive, physiologic and metabolic processes10, and physi-
ological parameters such as water intake (WI), diuresis (DIU) and water balance (WB). We also investigated the 
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correlations between these neuropeptidase activities from the left and right frontal cortex with some metabolic 
factors determined in plasma (such as high-density lipoprotein (HDL), low-density lipoprotein (LDL), HDL/
LDL, glucose (GLU) and nitric oxide (NO) and urine (such as proteinuria, NO and creatinine). These studies were 
performed in nontreated (control (CT)) Wistar Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) 
and in the same strains treated with vasoactive drugs such as the angiotensin-converting enzyme (ACE) inhibitor 
captopril (CAP), the beta-blocker propranolol (PRO) and the nitric oxide synthase inhibitor L-nitro-arginine 
methyl ester (L-NAME or LN). These vasoactive drugs were selected on the basis of their different mechanism 
of action on the cardiovascular system and their opposite influence on blood pressure11. The activities of three 
neuropeptidases, alanyl aminopeptidase (AlaAP), involved in enkephalin and angiotensin III metabolism12,13, 
cystinyl aminopeptidase (CysAP), involved in oxytocin and vasopressin metabolism14, also identified as the 
insulin-regulated aminopeptidase (IRAP) or the Ang IV receptor (AT4)15, and glutamyl aminopeptidase (GluAP), 
involved in angiotensin II and cholecystokinin metabolism16 (Fig. 1), were measured fluorometrically using aryla-
mide derivatives as substrates17 as a reflection of the functional status of their endogenous substrates.
Results
physiologic parameters and metabolic factors. The levels of neuropeptidase activities in the left and 
right frontal cortex as well as the blood pressure values for the groups of animals included in this study were previ-
ously reported11. All of the groups with SHR demonstrated higher blood pressure values (mmHg) (mean ± SEM: 
CT 206.7 ± 6.8, CAP 159.3 ± 5.2, PRO 206.7 ± 3.8, LN 234.7 ± 4.1) than the corresponding groups with WKY 
rats (mean ± SEM: CT 143.7 ± 4.5, CAP 121.8 ± 11.3, PRO 139 ± 5.8, LN 215 ± 2.6). The highest blood pressure 
levels were observed in the LN group and the lowest in the CAP group in both WKY rats and SHR. No significant 
differences were observed between the CT and PRO groups in WKY rats and SHR11.
Figures 2 and 3 represent the mean ± SEM values of the different physiologic and metabolic parameters stud-
ied and the statistical significance of their comparisons, respectively, in the groups with SHR or WKY rats.
In WKY rats (Fig. 2), the CAP group exhibited the highest WI and DIU values, whereas the PRO group exhib-
ited the lowest. While CT and CAP groups did not differ between them for WB, the PRO group demonstrated 
the lowest levels of WB amongst groups. TCH levels were significantly lower in the CAP and LN groups than in 
the CT.
HDL in the LN group was lower than that in the CT and CAP groups, and LDL in the LN group was lower 
than that in the CT group. No differences between groups were observed for HDL/LDL values. GLU was higher 
in the CAP group than in the other groups and lower in the PRO and LN groups than in the CT and CAP groups. 
NO was lower in the PRO and LN groups than in the CT and CAP groups in both plasma and urine. The lowest 
levels of proteins and creatinine in urine were observed in the CAP group and the highest in the PRO group.
In SHR (Fig. 3), WI and DIU were lower in the PRO group than in the other groups. Furthermore, WB was 
lower in the PRO and LN groups than in the CT group. TCH was higher in the LN group than in the CAP group. 
While no differences between groups were observed for HDL and HDL/LDL, LDL was higher in the LN group 
than in the CAP group. GLU was lower in the PRO group than in the CAP group, and plasma NO was lower in the 
LN group than in the CT and CAP groups. In urine, NO was lower in the CT group than in the other groups. The 
Figure 1. Potential endogenous substrates of the enzymatic activities analyzed in the present work. 
Glutamyl aminopeptidase (GluAP, EC 3.4.11.7)) metabolizes Ang II to produce Ang III and also hydrolyzes 
cholecystokinin (CCK)16. Alanyl aminopeptidase (AlaAP, EC 3.4.11.2) metabolizes Ang III to form Ang IV13 
and also acts as enkephalinase12 regulating enkephalin (ENK) function. Cystinyl aminopeptidase (CysAP, EC 
3.4.11.3) which has been reported to be the Ang IV receptor (AT4)15 or the insulin-regulated aminopeptidase 
(IRAP), involved in cell glucose uptake15, also acts as oxytocinase and vasopressinase14 regulating oxytocin (OX) 
and vasopressin (antidiuretic hormone, ADH). Partial steps of the enzymatic cascade of the renin-angiotensin 
system (RAS) are represented in the diagram.
3Scientific RepoRtS |         (2019) 9:16098  | https://doi.org/10.1038/s41598-019-52658-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
levels of proteinuria were highest in the LN group, and the levels of creatinine in urine were higher in the PRO 
group than in the other groups.
Comparisons of functional and metabolic parameters between SHR and WKY rats are illustrated in Fig. 4. In 
controls, SHR demonstrated higher values than WKY for WI (P < 0.001), WB (P < 0.001), LDL (P < 0.05) and 
creatinine (P < 0.01). In contrast, HDL (P < 0.01), HDL/LDL (P < 0.001) and NO Pl (P < 0.05) predominated 
significantly in WKY. In captopril treated animals, WI (P < 0.001), DIU (P < 0.001) and HDL (P < 0.05) pre-
dominated significantly in WKY whereas proteinuria (P < 0.001) and creatinine (P < 0.001) prevailed in SHR. In 
propranolol treated rats, while WI (P < 0.001), WB (P < 0.01), LDL (P < 0.05), NO Ur (P < 0.001) and creatinine 
(P < 0.001) predominated in SHR, only proteinuria (P < 0.001) prevailed significantly in WKY. In the L-NAME 
group, WI (P < 0.01), DIU (P < 0.001), TCH (P < 0.001), LDL (P < 0.01), GLU (P < 0.01), NO Ur (P < 0.01) and 
proteinuria (P < 0.001) predominated in SHR whereas HDL/LDL (P < 0.001) and NO Pl (P < 0.001) predomi-
nated in WKY.
correlational study. The results of the correlational study are shown in Tables 1, 2 and 3 and represented in 
Figs 5 and 6. Considering the values of the four groups (Table 1, Fig. 5), the comparison between Sol or MB neu-
ropeptidase activities from the left or right frontal cortex versus the physiologic parameters or metabolic factors 
in plasma or urine of WKY rats or SHR demonstrated that the most correlations were found between neuropepti-
dase activities of the left frontal cortex in WKY rats. Most of these correlations were positive in nature and mainly 
with MB enzyme activities. However, within these correlations, a few negative correlations were observed with 
proteins and creatinine in urine (Table 1, Fig. 5).
Each strain of rats can be independently assessed depending on the type of treatment. In WKY rats (Table 2, 
Fig. 6), most of the correlations were observed in the CAP group with neuropeptidase activities from both the 
left and right frontal cortex. In the PRO group, only neuropeptidases from the right frontal cortex correlated with 
metabolic factors, mainly LDL. Few correlations were observed in the CT and LN groups. In SHR (Table 3, Fig. 6), 
while the CT and PRO groups exhibited few correlations, the CT group showed only correlations with the right 
frontal cortex whereas the PRO group showed correlations only with the left frontal cortex. More correlations 
Figure 2. Mean ± SEM levels of the different physiologic parameters and metabolic factors measured in plasma 
and urine of Wistar Kyoto (WKY) rats (n = 8). Control (CT), captopril (CAP), propranolol (PRO) L-NAME 
(LN). (a) Comparison vs CT, (b) vs CAP, (c) vs PRO; single letter p < 0.05, double letter p < 0.01, triple letter 
p < 0.001. WI, water intake; DIU, diuresis; WB, water balance; TCH, total cholesterol; HDL, high-density 
lipoprotein; LDL, low-density lipoprotein; GLU, glucose; NO Pl, nitric oxide plasma; NO Ur, nitric oxide urine.
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were observed in the CAP group with both the left and right frontal cortex. In the LN group, the correlations were 
mostly with the right frontal cortex and negative.
Discussion
In summary, the present results suggest (1) that while CAP treatment may have led to a bilateral connection 
between both the left and right frontal cortex with physiologic/metabolic parameters in both SHR and WKY rats, 
LN treatment induced a high number of correlations, mostly negative in nature, only with the right frontal cortex 
of SHR; (2) that vasoactive drug treatments may have modified the neuroendocrine connection by changing the 
predominance of the left or right frontal cortex in SHR and WKY rats; (3) that there are asymmetric neurovisceral 
connections, which may occur by the conversion of a neural impulse, involving the left or right frontal cortex, into 
secretion of different neuropeptidase-dependent relevant hormones that affect biological/metabolic parameters; 
(4) that neuropeptidases of the frontal cortex may play a role in regulating physiologic/metabolic parameters; and 
5) that, considering the left and right behavior of aminopeptidase activities in the frontal cortex, CAP may have 
beneficial influence, whereas LN may have a deleterious one.
Previous results have revealed in frontal cortex specific asymmetrical patterns of some aminopeptidase activ-
ities in WKY that are altered in SHR11. These variations in asymmetries have been shown to be dependent on 
the enzymatic activity and the nature of the treatment. These results might be linked to cognitive alterations 
reported in these normotensive and hypertensive strains, which are affected by antihypertensive or hyperten-
sive drug treatment. Particularly, there was a trend to vary the prevalence of the cortex side of enzymatic activ-
ity or to raise the right dominance in SHR compared to that in WKY rats and when the animals were treated 
with the hypertensive drug LN. As discussed below, the predisposition to right prevalence in SHR was suggested 
by the intra- and inter-hemispheric correlations observed between neuropeptidase activities in frontal cortex. 
Considering the bilateral behavior of neuropeptidases, a clear favorable effect of CAP and a detrimental of LN 
were observed. These results are interesting because modifications in intra- and inter-hemispheric relationships 
have been demonstrated to be involved in human18 and animal19 mood disorders. In addition, hypertension 
may cause mood alterations, which may be part of the production and development of diverse cardiovascular 
Figure 3. Mean ± SEM levels of the different physiologic parameters and metabolic factors measured in plasma 
and urine of spontaneously hypertensive rats (SHR) (n = 8). Control (CT), captopril (CAP), propranolol (PRO) 
L-NAME (LN). (a) Comparison vs CT, (b) vs CAP, (c) vs PRO; single letter p < 0.05, double letter p < 0.01, 
triple letter p < 0.001. WI, water intake; DIU, diuresis; WB, water balance; TCH, total cholesterol; HDL, high-
density lipoprotein; LDL, low-density lipoprotein; GLU, glucose; NO Pl, nitric oxide plasma; NO Ur, nitric oxide 
urine.
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disorders, supporting a bidirectional connection between the cardiovascular system and brain. The purpose of the 
present research was to evaluate a possible lateralized interaction of certain neuropeptidase activities of the left 
or right frontal cortex versus various physiologic parameters or metabolic factors present in plasma or urine. The 
results clearly support such asymmetry in the brain that differs between normotensive and hypertensive subjects 
that is extended to virtually the entire organism.
The frontal cortex is related to cognitive functions and to the control of physiologic and metabolic processes10 
through its connection with the hypothalamus20. Endogenous substrates for the analyzed neuropeptidases in 
the frontal cortex include oxytocin (CysAP), vasopressin (CysAP), enkephalins (AlaAP), angiotensins (AlaAP, 
GluAP) and cholecystokinin (GluAP)21 (Fig. 1). All these neuropeptides are involved in cognitive functions, 
hydroelectrolytic balance or cardiovascular control10,22. The present results reveal an asymmetric neurometabolic 
interactive relationship between the brain and physiologic functions reflected in plasma and urine factors.
From the present results, several lines of evidence about systematic patterns of behavior could be highlighted 
and suggest, for instance, inverse relationships between the left versus the right sides of frontal cortex or between 
hypertensive (SHR) versus normotensive (WKY) rats. In this regard, considering the values of the four groups 
together, most correlations (Table 1, Fig. 5) were observed with the left frontal cortex of normotensive WKY rats, 
and most of these correlations were positive and associated with the MB fraction. This high number of correla-
tions may be interpreted as a basal predominance of the left frontal cortex for functional or metabolic processes 
that selectively change under vasoactive drug treatments. However, all the negative correlations were obtained 
selectively between MB activities vs. creatinine and proteins in urine. In contrast, SHR exhibited a remarkable 
predominance of negative correlations between activities in the Sol fraction of the right frontal cortex and param-
eters of aqueous balance. These observations suggest a divergence between WKY rats and SHR: in WKY rats, the 
correlations were predominantly positive and between activities in the MB fraction of the left frontal cortex and 
aqueous balance parameters, whereas in SHR, the prevalent correlations were negative between activities in the 
Figure 4. Comparisons of functional and metabolic parameters between WKY and SHR. Bars indicate the 
percentages of predominance of each parameter in WKY or SHR obtained from mean values of both strains in 
control, captopril, propranolol and L-NAME treated groups. Positive (blue) values indicate predominance in 
WKY. Negative (red) values indicate predominance in SHR. Values of creatinine (Creat) in captopril group and 
proteinuria (Protur) in the L-NAME group are ten folds (X10) higher. Asterisks indicate the level of significance 
when the corresponding parameter was compared between WKY and SHR. H, higher mean value; L, lower 
mean value. *P < 0.05, **P < 0.01; ***P < 0.001.
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Sol fraction of the right frontal cortex. Previous reports demonstrated an opposite behavior of aminopeptidase 
activities when hypothalamus versus plasma were compared in WKY or SHR and a divergent response when the 
hypothalamus and plasma were compared between WKY and SHR after PRO treatment (Fig. 7). This is support-
ing the association of the sympathetic nervous system in the regulation of these enzymatic activities23. The present 
results also suggest such divergence in the PRO group: while negative correlations with the right frontal cortex 
predominated in the WKY rats (without correlations with the left frontal cortex), SHR only demonstrated positive 
correlations with the left frontal cortex (without correlations with the right).
This divergent behavior is also highlighted by examining the results from another perspective: the correlations 
between the analyzed factors or the observed physiological parameters were established with specific neuropepti-
dases measured in samples collected from only one side of the frontal cortex, meaning that the same activity never 
correlated with the same factor on both sides. In instances when both the Sol and MB forms of the same enzyme 
correlated with the same parameter in the same group on both sides of the frontal cortex, the correlation was in 
the opposite direction, positive vs. negative, for the Sol and MB fractions. For example, whereas creatinine in 
the CAP group of WKY rats was positively correlated with Sol GluAP of the right frontal cortex, it was negatively 
correlated with MB GluAP of the left cortex (see Table 2). In SHR, WB in the CAP group was negatively correlated 
with Sol GluAP of the right cortex but positively correlated with MB GluAP of the left side. In addition, whereas 
WKY SHR
LEFT RIGHT LEFT RIGHT
Correlation r p Correlation r p Correlation r p Correlation r p
Sol AlaAP vs 
TCH +0.495 0.003
Sol CysAP 
vs HDL +0.402 0.02
Sol AlaAP 
vs NO Ur −0.481 0.005
Sol CysAP 
vs WB −0.501 0.002
Sol CysAP 
vs WI +0.461 0.007
Sol GluAP 
vs HDL −0.511 0.002
MB CysAP 
vs NO Ur +0.469 0.006
Sol GluAP 
vs WI −0.409 0.02
Sol CysAP 
vs DIU +0.509 0.002
MB AlaAP 
vs WB +0.475 0.005
MB CysAP 
vs Creat +0.408 0.02
Sol GluAP 
vs WB −0.419 0.01
Sol CysAP 
vs GLU +0.621 0.0001
MB GluAP 
vs TCH +0.453 0.009
MB CysAP 




vs DIU +0.437 0.01
MB AlaAP 
vs WB +0.446 0.01
MB AlaAP 
vs GLU +0.675 <0.0001
MB AlaAP 
vs NO Pl +0.498 0.003
MB AlaAP 
vs Protur −0.403 0.02
MB AlaAP 
vs Creat −0.433 0.01
MB CysAP 
vs WI +0.438 0.01
MB CysAP 
vs WB +0.534 0.001
MB CysAP 
vs GLU +0.545 0.001
MB CysAP 
vs NO Pl +0.474 0.005
MB CysAP 
vs Creat −0.404 0.02
MB GluAP 
vs WI +0.612 0.0002
MB GluAP 
vs DIU +0.649 <0.0001
MB GluAP 
vs GLU +0.400 0.02
MB GluAP 
vs Creat −0.428 0.01
Table 1. Left and right frontal cortex vs. physiologic and metabolic parameters regardless of drug treatment. 
Significant correlations between soluble (Sol) or membrane-bound (MB) aminopeptidase activities of the left or 
right frontal cortex with the different physiologic parameters or metabolic factors measured in plasma and urine 
in WKY rats and SHR, considering the data of the four groups all together. Pearson’s correlation coefficients 
(r) and p values are indicated. Negative correlations highlighted in italics. WI, water intake; DIU, diuresis; WB, 
water balance; TCH, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; GLU, 
glucose; NO Pl, nitric oxide in plasma; NO Ur, nitric oxide in urine; Protur, proteinuria; Creat, creatinine.
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Sol GluAP of the right frontal cortex was positively correlated with NO in urine, MB GluAP of the left side was 
negatively correlated (see Table 3).
Figure 8 comparatively analyzes the results of the correlations previously obtained within the frontal cor-
tex11 with the correlations obtained between the cortex and the peripheral parameters (present results). In WKY 
rats, treatment with CAP decreased blood pressure levels and resulted in greater the intrahemispheric correla-
tions between neuropeptidases in the left frontal cortex than in the right frontal cortex. In contrast, hypertension 
generated by LN treatment increased the intrahemispheric correlations on the right side. In SHR, high blood 
pressure levels (CT group) and increased blood pressure after treatment with LN (LN group) resulted in larger 
intrahemispheric correlations between neuropeptidases in the right frontal cortex than in the left frontal cortex. 
An examination of the interhemispheric correlations between neuropeptidases of the left and right frontal cortex 
in SHR and WKY rats reveals that the correlations did not appear in the untreated animals (SHR CT) and in those 
treated with LN. However, antihypertensive treatment (CAP and PRO) maintained the correlations, although to 
a lesser extent, indicating that hypertension decreases the interhemispheric correlation, whereas antihypertensive 
treatment maintains it. In the WKY rats, treatment with CAP favored the correlations between the peripheral 
parameters and neuropeptidases of both the left and right frontal cortex, while treatment with PRO enhanced 
correlations only with the right side. The CT and LN groups of WKY rats showed few or no correlations with both 
the right and left sides. In SHR, treatment with CAP also increased correlations with both the left and right frontal 
cortex. In the CT and LN groups of SHR, the correlations with the right side increased. These results suggest that 
hypertension and its increase with LN treatment induced a predominance of correlations with the right side, 
suggesting a beneficial influence of CAP and detrimental effect of LN.
Most of the aqueous balance parameters and urine metabolites correlated with the left or right frontal cor-
tex in the CAP group of WKY rats and SHR (Tables 2 and 3). An increase in DIU after CAP treatment is a 
well-known effect, especially in WKY rats24. These results may be related to a previous study14, which suggested 
that in CAP-treated rats, CysAP, which acts mainly in the renal medulla, may regulate fluid balance. Regarding 
the connection of these parameters with brain asymmetry, Bianki et al.25 reported that both right or left hemi-
sphere inactivation with potassium induced a similar response in water consumption. However, when animals 
were stronger motivated to drink, the right hemisphere predominated but when the motivation was weaker, the 
left hemisphere prevailed.
For lipids, the correlations were clearly asymmetric depending on the treatment and strain. In WKY rats, 
while correlations with the left side predominated in the CAP group, correlation with the right frontal cortex 
dominated in the group treated with PRO (Table 2). In SHR, most correlations with lipids were observed with the 
right side in the LN group (Table 3). No studies have associated brain asymmetry with lipid metabolism or hepatic 
function. Only Nikolaeva et al.26,27, as discussed below, reported a relationship between left or right handers and 
lipid metabolism. The liver connects with the hypothalamus through the autonomic nervous system28 and par-
ticularly with the frontal cortex20. The hypothalamus-liver connection also influences triglyceride metabolism 
through the sympathetic system29, which has also been shown to be related with the causes and development of 
LEFT RIGHT
Correlation r p Correlation r p
CONTROL
No correlations Sol GluAP vs HDL/LDL +0.822 0.01
CAPTOPRIL
Sol CysAP vs HDL/LDL +0.963 0.0001 Sol GluAP vs Creat +0.772 0.02
MB AlaAP vs HDL/
LDL +0.796 0.01 MB AlaAP vs WI +0.776 0.02
Sol CysAP vs LDL −0.915 0.001 MB CysAP vs Protur −0.788 0.01
MB AlaAP vs LDL −0.798 0.01 MB CysAP vs Creat −0.920 0.001
MB GluAP vs Creat −0.898 0.002 MB GluAP vs Protur −0.774 0.02
Sol CysAP vs NO Ur −0.828 0.01
PROPRANOLOL
Sol GluAP vs LDL +0.791 0.01
No correlations Sol CysAP vs LDL −0.791 0.01
MB AlaAP vs LDL −0.762 0.02
MB GluAP vs NO Ur −0.770 0.02
L-NAME
Sol AlaAP vs TCH +0.756 0.02 No correlations
MB GluAP vs HDL −0.818 0.01
Table 2. Left and right frontal cortex vs. physiologic and metabolic parameters in each group of WKY rats. 
Significant correlations between soluble (Sol) and membrane-bound (MB) neuropeptidase activities of the left 
and right frontal cortex with the different physiologic parameters and metabolic factors measured in plasma 
and urine in WKY rats, considering each of the four drug treatment groups independently. Pearson’s correlation 
coefficients (r) and p values are indicated. Negative correlations highlighted in italics. WI, water intake; 
DIU, diuresis; WB, water balance; TCH, total cholesterol; HDL, high-density lipoprotein; LDL, low-density 
lipoprotein; NO Ur, nitric oxide in urine; Protur, proteinuria; Creat, creatinine.
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metabolic syndrome30. The pattern of distribution of fatty acids in the frontal cortex is associated to the type of fat 
we have used in the diet and some of these fatty acids correlate significantly with certain aminopeptidase activities 
of the frontal cortex, suggesting not only a connection between peripheral tissues and the frontal cortex, presum-
ably through the autonomic nervous system, but also that cognitive processes could be modified depending on 
the kind of fat with which we prepared the diet31.
Interestingly, GLU only correlated with the frontal cortex in SHR groups: positively with the right side in the 
CT group and with the left side in the LN group and negatively with the right frontal cortex in the CAP group 
(Table 3). LN treatment has been demonstrated to increase glycemia more in SHR than in WKY rats, probably 
due to the concomitant increase in insulin in WKY rats that is not present in SHR32, which is clearly supported 
with the present results (Fig. 4). Walters et al.33 have related high plasma GLU levels to alterations in the bilateral 
functioning of the frontal cortex, which in turn is associated with cognitive alterations.
Changes in the asymmetries of the frontal cortex can not only have cognitive consequences but they also affect 
peripheral and metabolic functions through the control that the left and right frontal cortex exert on the left and 
right hypothalamus and as a consequence on the autonomic nervous system (ANS). We have previously spec-
ulated on the mechanism of neurovisceral connection between hypothalamus, heart and kidney34 and demon-
strated neurofunctional asymmetries that connect the activity of GluAP of the left or right frontal cortex with the 
left or right turning behavior of the rat35. Also, we showed neurometabolic asymmetries that connect a cerebral 
asymmetry in the content of dopamine with changes in plasma levels of GluAP and NO in the rat36. Similar 
asymmetry also affected heart function of rats37. All these consequences are presumably involving the ANS34,36,37. 
The asymmetric functioning of the frontal cortex can partly condition the asymmetric behavior of the ANS and 
consequently differentially determine the metabolic response of the organism and vice versa. Thus, the animal’s 
metabolic state can influence the lateralized functional predominance of the frontal cortex. Taking into account 
the reported connections between the frontal cortex and the hypothalamus38, considered as the main way to 
regulate autonomic and neuroendocrine responses39, we could hypothesize a lateralized bidirectional flow of neu-
ropeptidases through axonal vesicular transportation between the frontal cortex and the hypothalamus, as well 
as between the latter and peripheral tissues, through the ANS (Fig. 9). Neuropeptidases would act by regulating 
LEFT RIGHT
Correlation r p Correlation r p
CONTROL
MB CysAP vs WB +0.836 0.009
No correlations MB AlaAP vs GLU +0.801 0.01
MB GluAP vs NO Pl +0.773 0.02
CAPTOPRIL
MB GluAP vs WB +0.917 0.001 MB CysAP vs Protur +0.946 0.0003
MB GluAP vs HDL +0.796 0.01 Sol AlaAP vs NO Ur +0.849 0.007
MB GluAP vs WI +0.904 0.002 Sol GluAP vs NO Ur +0.781 0.02
MB AlaAP vs DIU +0.859 0.006 Sol GluAP vs WB −0.792 0.01
Sol CysAP vs Creat +0.781 0.02 Sol CysAP vs GLU −0.824 0.01
MB AlaAP vs Creat −0.778 0.02 Sol GluAP vs GLU −0.816 0.01
MB GluAP vs NO Ur −0.911 0.001 Sol AlaAP vs WB −0.758 0.02
PROPRANOLOL
MB GluAP vs TCH +0.830 0.01 No correlations
MB GluAP vs Creat +0.862 0.005
L−NAME
MB AlaAP vs DIU +0.912 0.001 Sol AlaAP vs TCH +0.781 0.02
MB GluAP vs GLU +0.896 0.002 Sol AlaAP vs LDL +0.973 <0.0001
Sol CysAP vs WI −0.892 0.002
Sol GluAP vs WI −0.879 0.004
MB GluAP vs WI −0.788 0.02
Sol GluAP vs HDL −0.757 0.02
Sol AlaAP vs HDL/LDL −0.826 0.01
Sol GluAP vs HDL/LDL −0.793 0.02
Table 3. Left and right frontal cortex vs. physiologic and metabolic parameters in each group of SHR. 
Significant correlations between soluble (Sol) and membrane-bound (MB) aminopeptidase activities of the left 
and right frontal cortex with the different physiologic parameters and metabolic factors measured in plasma 
and urine in SHR, considering each of the four drug treatment groups independently. Pearson’s correlation 
coefficients (r) and p values are indicated. Negative correlations highlighted in italics. WI, water intake; 
DIU, diuresis; WB, water balance; TCH, total cholesterol; HDL, high-density lipoprotein; LDL, low-density 
lipoprotein; GLU, glucose; NO Pl, nitric oxide in plasma; NO Ur, nitric oxide in urine; Protur, proteinuria; 
Creat, creatinine.
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their respective endogenous substrates (neuropeptides) centrally as well as in peripheral target tissues (peptides) 
and consequently, the physiological and/or metabolic functions that they could exert.
Considering the relationship: “increase in enzyme activity/decrease in the level of the susceptible substrates” 
and vice versa, the susceptible endogenous substrates of the enzymes analyzed (Fig. 1) may disclose, in general 
terms, the functional status of these substrates, revealing a predominance of the left or right frontal cortex, in 
connection with certain peripheral parameters. Particularly, focusing on specific results, we could suggest for 
example that in WKY, there was a clear increase in both sides of significant neurometabolic correlations after CAP 
treatment and a predominance biased to the right side with PRO treatment (Table 2). Specifically, for example, in 
the left frontal cortex, after CAP treatment there was an inverse correlation between CysAP and AlaAP with LDL 
(Table 2): the higher CysAP and AlaAP/the lower LDL and vice versa. This may mean that an increase of both 
activities in the left frontal cortex would be compatible with a decrease in ADH levels, a decrease in Ang III and 
an increase in Ang IV on the left side, which would be related to low plasma LDL levels. The opposite could be 
suggested with the decrease of both activities in the left frontal cortex. In SHR, the high frequency of significant 
correlations on both sides of the frontal cortex after CAP treatment is also observed and a shift towards the right 
predominance appears after L-NAME treatment. In particular, in the left frontal cortex, a highly significant pos-
itive correlation was observed between GluAP and AlaAP with water balance parameters (WI, DIU, WB) after 
CAP treatment (Table 3): the higher GluAP and AlaAP/the higher water balance parameters. This result may 
suggest that an increase of GluAP reflects decreased levels of Ang II together with increased Ang III and also that 
an increase of AlaAP involves a decrease of Ang III and an increase of Ang IV that would be directly related, as a 
consequence, with increased aqueous balance parameters (Table 3). Indeed, the neuropeptide Ang IV has been 
reported to be involved with water balance40. Therefore, these results could be well-matched with a significant 
role of Ang IV in the left frontal cortex in relation with aqueous balance after CAP treatment. In any case, further 
research would be necessary to conclusively be able to relate specific physiological functions or precise metabolic 
states with lateralization of neuropeptidases in the frontal cortex.
In conclusion, the present results describe for the first time asymmetric correlations between peripheral meta-
bolic factors, physiologic processes and neuropeptidase activities in the frontal cortex. Such asymmetric changes 
occur depending on the strain and antihypertensive or hypertensive drug treatment. This observation definitively 
supports an asymmetric organization of neurovisceral integration. These results may be important in light of not 
only unexpected consequences of antihypertensive treatments but also of unilateral cerebral insults or pathologies 
such as Parkinson’s or Alzheimer’s diseases, schizophrenia or depressive disorders7, in which a unilateral origin 
and development, has clearly been established.
Figure 5. Schematic representation of all the significant positive (blue lines) and negative (red lines) 
correlations between neuropeptidase activities (AlaAP, CysAP, GluAP) of the left and right frontal cortex with 
physiologic parameters (WI, DIU, WB), plasma factors (TCH, HDL, LDL, HDL/LDL, GLU, NO Pl) and urine 
metabolites (NO Ur, Proteinuria, Creatinine) in Wistar Kyoto (WKY) rats and spontaneously hypertensive rats 
(SHR), without considering the type of drug treatment. The thickness of the lines is proportional to the level 
of significance and to the number of significant correlations between variables. The meaning of the schematic 
drawings is indicated in the left side of the scheme.
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Figure 6. Schematic representation of the significant correlations between neuropeptidase activities of the 
left and right frontal cortex and plasma factors, physiologic parameters and urine metabolites in each of the 
four groups of Wistar Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) depending on the type of 
treatment: Control (CT), captopril (CAP), propranolol (PRO), and L-NAME (LN). Positive correlations are in 
blue and negative in red. The thickness of lines is proportional to the level of significance and the number of 
significant correlations between variables. The meaning of the schematic drawings is shown in Fig. 5.
Figure 7. Schematic representation of the divergent response of aminopeptidase activities between the 
hypothalamus (HT) versus plasma (PL) of Wistar Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) 
after treatment with propranolol. While the HT and PL response diverges between WKY rats and SHR, the HT 
and PL response also diverges within each strain23.
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Materials and Methods
Study design. Thirty-two adult male WKY rats and thirty-two adult male SHR, weighing 100 to 150 g at the 
beginning of the experiments, were used in this study11. Each strain was divided into untreated CT (n = 8), CAP 
(n = 8), PRO (n = 8) and LN (n = 8) groups. CAP (Sigma, 100 mg/kg/day), PRO (Sigma, 100 mg/kg/day) and LN 
(Sigma 70 mg/kg/day) were added to the drinking water of the corresponding group during four weeks11. The 
dosages as well as the period of treatment were previously described as suitable to reach the entire action of the 
drugs41,42. To prevent the effect of circadian or seasonal variations, the experiments were performed in summer 
under environmental light conditions between 9:00 a.m. and 12:00 noon7,11. The study was carried out according 
to the European Communities Council Directive 86/609/EEC and received approval from the bioethics com-
mittee of the University of Jaén. To measure WI and DIU and to obtain urine samples, we singly housed rats in 
metabolic cages 24 h prior to sacrifice, and WB was calculated subtracting DIU from WI14.
Surgical procedure, tissue collection and plasma or urine determinations. After four weeks of the 
corresponding treatments and after recording systolic blood pressure11, animals were anesthetized with equithen-
sin (2 ml/kg body weight; 42.5 g/l chloral hydrate dissolved in 19.76 ml ethanol, 9.72 g/l Nembutal ©, 0.396 l/l 
propylenglycol, and 21.3 g/l magnesium sulfate in distilled water)11, and samples of blood were obtained from 
the left cardiac ventricle8. The animals were perfused with saline solution through the left cardiac ventricle and 
sacrificed9. The brain was quickly removed (less than 60 s), and the left and right frontal cortices were dissected11 
according to the stereotaxic Paxinos and Watson atlas43. The selected area was between the anterior left or right 
border of the frontal lobe up to 13.2 mm anterior to the interaural line11. Brain samples were used to determine 
neuropeptidase activities in their soluble (Sol) and membrane-bound (MB) forms as described below11. Plasma 
was isolated by centrifugation of blood samples for 10 min at 2000 g using heparin as an anticoagulant and stored 
at −20 °C8. Total plasma cholesterol was determined colorimetrically using kits supplied by Sigma (St Louis, MO, 
352-50)44. HDL cholesterol precipitated with phosphotungstic acid was quantified with the same method44. LDL 
cholesterol fractions were calculated using Friedewald’s formula44. NO levels in plasma and urine were analyzed 
as previously described36. Proteins and creatinine in urine and plasma GLU were determined colorimetrically 
using kits supplied by Spinreact (Girona, Spain).
Figure 8. Comparative schematic representation of the total significant intrahemispheric (A) and 
interhemispheric (B) correlations previously obtained within the left or right frontal cortex (A) and between the 
left vs right frontal cortex (B)11 with the total correlations obtained between the left or right frontal cortex versus 
peripheral parameters (neurometabolic) (present results) (C) in the control (CT), captopril (CAP), propranolol 
(PRO) and L-NAME (LN) groups of Wistar Kyoto (WKY) rats and spontaneously hypertensive rats (SHR). The 
size of colored bars for CT, CAP, PRO or LN is proportional to the number of significant correlations obtained. 
Drawings of the left side of the figure illustrate the studied correlations. (A) Intrahemispheric correlations 
between neuropeptidase activities within the left or right frontal cortex11. (B) Interhemispheric correlations 
between the neuropeptidases of the left versus the neuropeptidases of the right frontal cortex11. (C) Significant 
correlations obtained between the left or right frontal cortex versus the peripheral functional, plasma or urine 
parameters.
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enzymatic and protein assays. Enzymatic assays were performed as previously described17. To obtain 
the Sol fraction, we homogenized brain samples in a hypoosmolar medium (10 mM HCl-Tris buffer, pH 7.4) and 
ultracentrifuged them at 100,000 g for 30 min at 4 °C. The supernatants were used for Sol protein and enzyme 
assays. To obtain the particulate fraction, the pellets were rehomogenized in HCl-Tris buffer (pH 7.4) plus 1% 
Triton X-100 to solubilize MB proteins. After centrifugation (100,000 g, 30 min, 4 °C), the protein level and activ-
ity of MB enzymes were measured in triplicate in the supernatants. To ensure complete recovery of activity, 
we removed the detergent from the medium by adding adsorbent polymeric Bio-Beads SM-2 (Sigma) (100 mg/
ml) and shaking the samples for 2 h at 4 °C. The activity of Sol and MB neuropeptidases, measured as GluAP, 
AlaAP and CysAP, was determined fluorometrically using the arylamide derivatives glutamyl-, alanyl- and 
cystinyl-β-naphthylamide as substrates as previously described17.
Briefly, GluAP levels were determined using Glu-β-naphthylamide as a substrate: 10 μl of each supernatant 
was incubated for 120 min at 37 °C with 1 ml of the substrate solution (2.72 mg/100 ml Glu-β-naphthylamide, 
10 mg/100 ml bovine serum albumin (BSA), 10 mg/100 ml dithiothreitol (DTT) and 0.555 g/100 ml CaCl2 in 
50 mmol/l HCl-Tris, pH 7.4). AlaAP and CysAP levels were measured using Ala- or Cys-β-naphthylamide as 
substrates, such that 10 µl of each supernatant was incubated for 30 min at 25 °C with 1 ml of the substrate solu-
tion, i.e., 2.14 mg/100 ml of Ala-β-naphthylamide or 5.53 mg/100 ml of Cys-β-naphthylamide, 10 mg/100 ml BSA, 
and 10 mg/ 100 ml DTT in 50 mM of phosphate buffer (pH 7.4 for AlaAP) and 50 mM HCl-Tris buffer (pH 6 for 
CysAP). The reactions were terminated by the addition of 1 ml of 0.1 mol/l of acetate buffer, pH 4.2. The amount 
of β-naphthylamine released as a result of the enzymatic activity was measured fluorometrically at a 412 nm 
emission wavelength with an excitation wavelength of 345 nm17. Proteins were quantified in triplicate using the 
Bradford method45 with BSA as a standard. Specific Sol or MB aminopeptidase activity was expressed as pmol of 
the corresponding substrate hydrolyzed per min per mg of protein. Fluorogenic assays were linear with respect to 
time of hydrolysis and protein content17.
Statistical analysis. In order to reach the objectives of the study, we carried out three statistical analyses:
 (1) A descriptive analysis using count per group, mean and standard deviation for each covariate.
Figure 9. Illustrative scheme of the proposed mechanism for a possible functional and neurometabolic 
asymmetrical connection between the left and right frontal cortex and peripheral tissues through bidirectional 
pathways connecting frontal cortex and hypothalamus, as well as hypothalamus and target tissues through the 
autonomic nervous system, in which neuropeptidases (black triangles) would be involved.
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 (2) A three-factor ANOVA for each of the enzymatic activities analyzed with the following factors: (a) The 
factor group with four categories (CT, CAP, PRO and LN). (b) The factor hemisphere (with two categories: 
left and right) crossed with group. (c) The factor rat, with eight rats nested in each group and two meas-
ures for each rat in each hemisphere. The group and hemisphere factors were fixed-effect factors, and the 
factor rat was a random effect factor. The analysis was carried out using a multilevel mixed model46. The 
group-by-hemisphere interaction was the first test considered, and if significant (P < 0.10), then pairwise 
comparisons between hemispheres within groups and among groups within hemispheres were carried out 
using Tukey’s penalization because of the balanced sample sizes47,48. If the interaction was not significant, 
independent tests among groups and between hemispheres were carried out.
 (3) With other variates such as WI, DIU, WB, TCH, HDL, LDL, HDL/LDL, GLU, NO Pl, NO Ur, Proteinuria 
and Creatinine, a two factor ANOVA was carried out: a) the factor strain with two levels SHR and WKY 
and (b) the factor treatment with four categories (CT, CAP, PRO and LN). Because for all the variates the 
interaction was significant, comparisons of variate by variate in the second factor, using the classical t-test 
with Tukey´s penalization, were done.
 (4) Since the existence of correlations between enzymatic activities in the two hemispheres, a multivariate 
linear regression was used to study the correlation between the different covariates with each one of the 
enzymatic activities of the left and right frontal cortex. Because there was an induced variability by group, 
two analyses were carried out: (a) an unadjusted analysis of each covariate with the enzymatic activity in 
each hemisphere and (b) an adjusted analysis by group of each covariate with the enzymatic activity in 
each hemisphere. Corrections for the number of tests were not made because of the intrinsic exploratory 
nature of this analysis. Therefore, the obtained statistical significances should be taken with caution and be 
considered as suggestions.
All analyses were carried out with Stata 14.1.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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